Hepatitis B markers in heterosexual patients attending two genitourinary medicine clinics in the West Midlands

Genitourinary Medicine

Volumn 73, Issue 2, 1997, Pages 127-130

  El Dalil, A A ^b   Jayaweera, D T ^a   Walzman, M ^a   Radcliffe, K W ^a   Richmond, R ^a   Wade, A A ^a   Shahmanesh, M ^a  

^a Hospital of Coventry and Warwickshire   (United Kingdom)

^b The Guest Hospital   (United Kingdom)

Author keywords

Hepatitis B; Heterosexuals; Markers

Indexed keywords

MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HETEROSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030913665     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.73.2.127     Document Type: Article

References (15)

1. Maynard JE, Kane NA, Alter MJ, Hadler SC. Control of hepatitis B by immunization: global perspective. In: Zuckerman AJ, ed. Hepatitis and Liver Disease. New York, NY: Alan R Liss Inc, 1988:967-9.
2. Perillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, et al. A randomised, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
3. Krugman S, Giles JP, Hammond J. Infectious hepatitis, evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967;200:365-73.
4. Prince AM, Hargrove RL, Szmuness W, Cherubin CE, Fontana VJ, Jeffries GH, et al. Immunologic distinction between infectious and serum hepatitis. N Engl J Med 1970;282:987-91.
5. Szmuness W, Prince AM. Epidemiologic patterns of viral hepatitis in Eastern Europe in the light of recent findings concerning the serum hepatitis antigen. J Infect Dis 1971;123:200-12.
6. London WT, Sutnick AI, Blumberg BS. Australia antigen and acute viral hepatitis. Ann Intern Med 1969;70:55-9.
7. Villarejos VM, Visona KA, Gutierrez A, Rodriguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med 1974;291:1375-8.
8. Van Doornum GJ, Van Haastrecht JH, Hooykaas C, Van Den Hoek JA, Van Der Linden MM, Coutinho RA, et al. Hepatitis B virus infection in a group of heterosexuals with multiple partners in Amsterdam, The Netherlands: implications for vaccination? J Med Virol 1994;43:20-7.
9. Barrett CL, Austin H, Louv WC, Alexander WJ, Hadler SC. Risk factors for hepatitis B virus infection among women attending a clinic for sexually transmitted diseases. Sex Transm Dis 1992;19:14-8.
10. Hou MC, Wu JC, Kuo BI, Sheng WY, Chen TZ, Lee SD, et al. Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan - the importance of extending vaccination to susceptible adults. J Infect Dis 1993;167:938-41.
11. Alter MJ, Hadler SC, Margolis HS, Alexander WJ, Hu PY, Judson FN, et al. The changing epidemiology of hepatitis B in the United States: Need for alternative vaccination strategies. JAMA 1990;263:1218-22.
12. Alter MJ, Ahtone J, Weisfuse I, Starko K, Vacalis TD, Maynard JE. Hepatitis B virus transmission between heterosexuals. JAMA 1986;256:1307-10.
13. Hentzer B, Skinhoj P, Hoybye G, Neilsen AO, Kvorning SA, Faver V, et al. Viral hepatitis in a venereal clinic population. Scand J Infect Dis 1980;12:245-9.
14. Siebke JC, Wessel N, Krandal P, Lie T. The prevalence of hepatitis A and B in Norwegian merchant seamen - a serological study. Infection 1989;17:77-80.
15. Gilson RJC. Sexually transmitted hepatitis: a review. Genitourin Med 1992;68:123-9.